Dr. Anne Ponce De Leon, MD

NPI: 1083649743
Total Payments
$75,166
2024 Payments
$11,912
Companies
19
Transactions
97

Payment Breakdown by Category

Consulting$69,493 (92.5%)
Food & Beverage$3,472 (4.6%)
Travel$1,726 (2.3%)
Education$475.00 (0.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $69,493 34 92.5%
Food and Beverage $3,472 58 4.6%
Travel and Lodging $1,726 4 2.3%
Education $475.00 1 0.6%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $69,968 35 $0 (2024)
Allergan Inc. $1,543 10 $0 (2019)
DAVOL INC. $1,129 4 $0 (2018)
Merz North America, Inc. $1,055 14 $0 (2023)
Galderma Laboratories, L.P. $340.77 4 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $234.07 3 $0 (2018)
GlaxoSmithKline, LLC. $158.42 5 $0 (2017)
Baxter Healthcare $145.37 1 $0 (2024)
Shire North American Group Inc $132.89 6 $0 (2018)
AbbVie, Inc. $117.98 2 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $11,912 6 Takeda Pharmaceuticals U.S.A., Inc. ($11,767)
2023 $14,295 17 Takeda Pharmaceuticals U.S.A., Inc. ($13,467)
2022 $29,250 19 Takeda Pharmaceuticals U.S.A., Inc. ($28,940)
2021 $16,045 12 Takeda Pharmaceuticals U.S.A., Inc. ($15,795)
2019 $1,397 9 Allergan Inc. ($1,374)
2018 $1,416 16 DAVOL INC. ($1,129)
2017 $851.80 18 Boehringer Ingelheim Pharmaceuticals, Inc. ($215.60)

All Payment Transactions

97 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,353.33 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,353.33 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,353.33 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,353.33 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,353.33 General
04/18/2024 Baxter Healthcare PERCLOT (Device) Food and Beverage In-kind items and services $145.37 General
Category: Surgical Care
12/15/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,353.33 General
11/10/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,353.33 General
10/13/2023 Abbott Laboratories ETERNA (Device) Food and Beverage In-kind items and services $20.69 General
Category: Neuromodulation
09/19/2023 Galderma Laboratories, L.P. DYSPORT (Biological) Food and Beverage In-kind items and services $15.84 General
08/18/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $900.00 General
06/14/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,353.33 General
04/07/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
03/18/2023 Merz North America, Inc. Xeomin (Biological) Food and Beverage In-kind items and services $300.00 General
Category: Dermatology
02/23/2023 Merz North America, Inc. Food and Beverage In-kind items and services $178.50 General
02/23/2023 Merz North America, Inc. Food and Beverage In-kind items and services $45.47 General
02/13/2023 Merz North America, Inc. Food and Beverage In-kind items and services $153.24 General
02/08/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
01/25/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,000.00 General
01/07/2023 Merz North America, Inc. Food and Beverage In-kind items and services $24.13 General
01/05/2023 Merz North America, Inc. Food and Beverage In-kind items and services $41.62 General
01/05/2023 Merz North America, Inc. Food and Beverage In-kind items and services $24.87 General
01/05/2023 Merz North America, Inc. Food and Beverage In-kind items and services $23.56 General
12/21/2022 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,000.00 General
12/07/2022 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General

About Dr. Anne Ponce De Leon, MD

Dr. Anne Ponce De Leon, MD is a Family Medicine healthcare provider based in Sugar Land, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083649743.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anne Ponce De Leon, MD has received a total of $75,166 in payments from pharmaceutical and medical device companies, with $11,912 received in 2024. These payments were reported across 97 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($69,493).

Practice Information

  • Specialty Family Medicine
  • Location Sugar Land, TX
  • Active Since 07/11/2006
  • Last Updated 04/10/2019
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1083649743

Products in Payments

  • ALLODERM (Device) $1,374
  • Xeomin (Biological) $300.00
  • STRATTICE (Device) $168.71
  • PERCLOT (Device) $145.37
  • JARDIANCE (Drug) $143.45
  • Androgel (Drug) $117.98
  • MYDAYIS (Drug) $114.09
  • 4-K (Device) $108.56
  • ANORO ELLIPTA (Drug) $91.99
  • OFEV (Drug) $90.62
  • SOLIQUA (Drug) $73.83
  • ANORO (Drug) $43.90
  • Hetlioz (Drug) $37.74
  • NP Thyroid (Drug) $22.79
  • SHINGRIX (Drug) $22.53
  • TRULICITY (Drug) $21.31
  • ETERNA (Device) $20.69
  • TOUJEO (Drug) $19.35
  • VYVANSE (Drug) $18.80
  • DYSPORT (Biological) $15.84

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Sugar Land